Back to Search
MICHAEL LIEBOWITZ, MD
MD
Psychiatry Physician
NPI: 1821150129Individual
Specialties, Licenses & Credentials
Psychiatric Hospital
Psychiatric Hospital
Code: 283Q00000X
Adult Mental Health Clinic/Center
Clinic/Center — Adult Mental Health
Code: 261QM0850X
158438(MA)
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
158438(MA)
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1997
Clinical Trials (3)
3
Linked Trials
0
Recruiting
2
With Results
Cariprazine Versus Placebo for Social Anxiety Disorder
NCT05384483COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder
NCT01316302COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression
NCT00237666COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.
PMID 19180583·Depress Anxiety·2009
8-other
Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale.
PMID 18781659·Depress Anxiety·2009
8-other
Ziprasidone monotherapy in bipolar II depression: an open trial.
PMID 19264363·J Affect Disord·2009
3-trial
A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
PMID 19358784·J Clin Psychiatry·2009
4-observational
Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
PMID 19194995·Depress Anxiety·2009
2-rct
Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls.
PMID 18800368·Depress Anxiety·2009
8-other
A double-masked, placebo-controlled study of fluoxetine for hypochondriasis.
PMID 19011432·J Clin Psychopharmacol·2008
4-observational
Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder.
PMID 18507895·Curr Med Res Opin·2008
4-observational
Long-term follow-up study of patients with refractory obsessive-compulsive disorder.
PMID 19196930·J Neuropsychiatry Clin Neurosci·2008
8-other
Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
PMID 18557666·J Clin Psychiatry·2008
8-other
Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings.
PMID 17252580·Depress Anxiety·2008
4-observational
A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
PMID 18316422·Am J Psychiatry·2008
2-rct
Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
PMID 18221755·J Psychiatr Res·2008
1-meta
Distorted maternal mental representations and atypical behavior in a clinical sample of violence-exposed mothers and their toddlers.
PMID 18985165·J Trauma Dissociation·2008
8-other
A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder.
PMID 17941096·Depress Anxiety·2008
4-observational
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.
PMID 18949648·World J Biol Psychiatry·2008
6-review
Features of the offensive subtype of Taijin-Kyofu-Sho in US and Korean patients with DSM-IV social anxiety disorder.
PMID 17340609·Depress Anxiety·2008
4-observational
Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research.
PMID 17892885·J Psychiatr Res·2008
4-observational
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.
PMID 17414743·Int Clin Psychopharmacol·2007
4-observational
National trends in ethnic disparities in mental health care.
PMID 18049340·Med Care·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 581 FAUNCE CORNER RD
DARTMOUTH, MA 02747 - Phone
- (508) 207-9800
Quick Facts
- NPI
- 1821150129
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 29
- Clinical Trials
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile